Investment in drug development co to fetch Jubilant Life upto $22.6mn
Jubilant Life Sciences today said its US arm stands to receive up to USD 22.6 million following the acquisition of a drug development firm, in which it has an indirect investment, by a pharmaceutical company which was not named.
Mar 29, 2016, 15:36 PM IST